The trajectory of Sildenafil presents a challenging picture for those considering investment. While the initial launch generated massive gains, the lapse of its patent opened the door to off-brand versions, https://mnobookmarks.com/story21548420/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet